Drawing for SENZO

USPTO serial 88731878

SENZO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
FIRST, VIVIAN M
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SENZO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James R Menker

JAMES R MENKER HOLLEY & MENKER PAPO BOX 331937ATLANTIC BEACH, FL 32233UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting sensory organs; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products for skin care for animals; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Preparations for destroying parasites; Preparations for treating colds; Vitamin A preparations; Vitamin and mineral formed and packaged as bars; Vitamin and mineral preparations for medical use; Vitamin and mineral supplements; Vitamin B preparations; Vitamin C preparations; Vitamin D preparations; Vitamin drops; Vitamin enriched chewing gum for medical purposes; Vitamin enriched sparkling water for medical purposes; Vitamin enriched water for medical purposes; Vitamin fortified beverages for medical purposes; Vitamin oils for human consumption; Vitamin preparations; Vitamin supplement in tablet form for use in making an effervescent beverage when added to water; Vitamin supplement patches; Vitamin supplements; Vitamin tablets; Vitamins; Vitamins and vitamin preparations; Vitamins and dietary food supplements for animals; Vitamins for pets; Aloe vera preparations for pharmaceutical purposes; Aloe vera preparations for therapeutic purposes; Amino acid preparations for veterinary purposes; Animal feed additive for use as a nutritional supplement for medical purposes; Anti-arthritic compositions and preparations; Anti-diabetic pharmaceuticals; Anti-drowsiness treatment preparations; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Athlete's foot preparations; Bacterial preparations for medical and veterinary use; Bacterial and bacteriological preparations for medical or veterinary purposes; Bacteriological preparations for medical and veterinary use; Balms for pharmaceutical purposes; Caffeine preparations for stimulative use; Caffeine preparations for stimulative use in the form of chewing gum; Calcium supplements; Chemical preparations to treat wheat smut; Cough treatment preparations; Dermatological pharmaceutical products; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Dietary supplement for eliminating toxins from the intestinal tract; Dietary supplements; Dietary supplements for animals; Dietary supplements for pets; Dietary supplements in the nature of weight loss powders; Dietary and nutritional supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements used for weight loss; Dietary food supplements; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietetic preparations adapted for medical purposes; Dieting pills and powder preparations to promote fat burning; Digestives for pharmaceutical purposes; Enzyme preparations for medical purposes; Enzyme preparations for veterinary purposes; Fertility enhancement preparations; Flea and tick treatment preparations for pets; Food supplements, namely, anti-oxidants; Fruit-based meal replacement bars for treating vitamin B12 deficiency that causes fatigue; Gastro-intestinal treatment preparations; Gummy vitamins; Hemorrhoid preparations; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Liquid vitamin supplements; Liquid nutritional supplement; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicated dermatological preparations and substances; Medicated mouth care and treatment preparations; Medicated skin care preparations; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated sun care preparations; Medicinal preparations for stimulating hair growth; Medicinal preparations for the mouth and as sprays; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Medicinal hair growth preparations; Medicinal herbal preparations; Menstrual symptom treatment preparations; Mineral preparations for medical purposes; Mineral, vitamin, or nutritionally enhanced water for medical purposes; Mixed vitamin preparations; Multi-vitamin preparations; Multivitamin preparations; Nasal cleaning preparations for medical purposes; Natural supplements for treating erectile dysfunction; Natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; Natural sleep aid preparations; Nausea treatment preparations; Nutritional supplement energy bars; Nutritional supplement for eliminating toxins from the body; Nutritional supplement for eliminating toxins from the intestinal tract; Nutritional supplement shakes; Nutritional supplements; Nutritional supplements, namely, probiotic compositions; Nutritional and dietary supplements formed and packaged as bars; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for use in dermatology; Pharmaceutical antitussive-cold preparations; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Plant extracts for pharmaceutical purposes; Potassium preparations for pharmaceutical purposes; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Prebiotic supplements; Prenatal vitamins; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Probiotic supplements; Products and preparations for cleansing the skin for medical use; Protein supplement shakes; Protein supplement shakes for weight gain purposes; Protein supplements for animals; Protein dietary supplements; Protein dietary supplements formed and packaged as bars; Sanitary preparations for medical use; Topical dermatological preparations that treat insect bites and stings; Vaginal preparations, namely, antifungals; Vegan protein for use as a nutritional supplement in ready-to-drink beverages; Veterinary pharmaceutical compounds for equine use to treat conditions of the leg, hoof, ear, nose and throat; Veterinary preparations for treatment of intestinal bacteria; Veterinary preparations, namely, antioxidants; Veterinary preparations, namely, pain relief medication; Weight management supplements; Whey protein supplementsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 27, 2023MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Feb 24, 2023ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Feb 24, 2023OP.TOPPOSITION TERMINATED NO. 999999—
Feb 24, 2023OP.SOPPOSITION SUSTAINED NO. 999999—
Apr 28, 2020OP.IOPPOSITION INSTITUTED NO. 999999—
Apr 28, 2020OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Apr 28, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 28, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 8, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 26, 2020FIXDELECTRONIC RECORD REVIEW COMPLETE—
Mar 20, 2020ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Mar 13, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 13, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 13, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 11, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 2, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 2, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Mar 2, 2020CNSLSUSPENSION LETTER WRITTEN—
Mar 2, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 2, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 2, 2020ALIEASSIGNED TO LIE—
Feb 26, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Feb 25, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 25, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 25, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 25, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 25, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 25, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 27, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 27, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Jan 27, 2020CNSLSUSPENSION LETTER WRITTEN—
Jan 27, 2020DOCKASSIGNED TO EXAMINER—
Dec 21, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 21, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance